Stephanie Okey
Director/Board Member at PTC THERAPEUTICS, INC.
Net worth: 437 293 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Matthew Klein | M | 52 | 5 years | |
| Alessandro Maselli | M | 52 | 14 years | |
| Scott Struthers | M | 62 | 16 years | |
| Ricky Hopson | M | 48 | 3 years | |
| Joseph Ferraro | M | 47 | 1 years | |
| Neil Almstead | M | 57 | 24 years | |
| Stephen Betz | M | 58 | 16 years | |
| Allan Jacobson | M | 78 | 26 years | |
| Christine Utter | F | 46 | 14 years | |
| J. Carroll | M | 74 | 9 years | |
| Michael Schmertzler | M | 72 | 23 years | |
| John Greisch | M | 68 | 6 years | |
| Rogério Vivaldi Coelho | M | 60 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 20 years |
| Ricardo Pravda | M | 53 | 19 years | |
| Ellen Welch | M | - | - | |
| Karen Murphy Santiago | F | 53 | 2 years | |
| Caren Deardorf | F | 59 | 2 years | |
| Scott Gunther | M | 57 | 12 years | |
| Mary Smith | F | 61 | 3 years | |
| Steven Barg | M | 62 | 1 years | |
| Dana Pizzuti | M | 69 | 2 years | |
| Michelle Ryan | F | 58 | 1 years | |
| Marc Wilson | M | 45 | 6 years | |
| Weston Nichols | M | 39 | 6 years | |
| Glenn Steele | M | 79 | 9 years | |
| Rolf Classon | M | 79 | 10 years | |
| Alethia Young | F | 45 | 2 years | |
| Emma Reeve | F | 63 | 6 years | |
| Wendell Wierenga | M | 76 | 9 years | |
| David Southwell | M | 63 | 19 years | |
| Frank D'Amelio | M | 66 | 1 years | |
| Gregory Lucier | M | 59 | 9 years | |
| Matthew Fust | M | 59 | 6 years | |
| Camille Bedrosian | M | 71 | 4 years | |
| Mark Boulding | M | 63 | 22 years | |
| Michael Barber | M | 64 | 3 years | |
| Jerome Zeldis | M | 74 | 12 years | |
| Martin Rexroad | M | - | 11 years | |
| Jack Stahl | M | 71 | 10 years | |
| Alan Krasner | M | 60 | 6 years | |
| Donald Morel | M | 67 | 9 years | |
| Jeff Knight | M | 53 | 3 years | |
| Jeanine Clemente | F | - | 5 years | |
| Kylie O'Keefe | F | - | 6 years | |
| Garlan Adams | F | - | 3 years | |
| Chris Robillard | M | - | 2 years | |
| Christelle Huguet | M | 57 | 1 years | |
| Brian Russell | M | - | 2 years | |
| William Bell | M | 67 | 1 years | |
| Michael Hatzfeld | M | 51 | - | |
| Hege Sollie-Zetlmayer | F | - | 6 years | |
| Adriana Cabré | F | - | 4 years | |
| James Hassard | M | 58 | 2 years | |
| Marla Weetall | M | - | 22 years | |
| Michelle Graham | F | 57 | 5 years | |
| Paul Streck | M | 60 | 2 years | |
| Matti Masanovich | M | 52 | 1 years | |
| François-Maurice Garnier | M | 62 | 1 years | |
| Paul Surdez | M | - | 4 years | |
| Murad Husain | M | - | 10 years | |
| Jacqueline Pomfret Kirby | F | - | 1 years | |
| Jennifer Benenson | F | - | 1 years | |
| Aymeric Le Chatelier | M | 55 | 1 years | |
| Pierre Gravier | M | 39 | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Meeker | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 23 years |
| Henri A. Termeer | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 28 years |
| Thomas A. Shea | M | 64 | - | |
| Mike Gutch | M | 58 | 8 years | |
| Steven Fasman | M | 61 | 9 years | |
| Stuart Peltz | M | 64 | 25 years | |
| Marcio Souza | M | 45 | 6 years | |
| Christopher Viehbacher | M | 64 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Catherine Moukheibir | F | 64 | 4 years | |
| William Sibold | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Sara Radcliffe | F | - |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | 4 years |
| Martin N. Bonde | M | 61 | 12 years | |
| Kristina Torfgård | M | 61 | 2 years | |
| Yamo Deniz | M | 60 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 4 years |
| John M. McPherson | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Michael Halpin | M | 62 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
| Julie Feder | F | 54 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Brian Schiller | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 10 years |
| Josias Fantato De Pontes | M | 58 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Jason G. Duncan | M | 50 | - | |
| Julia Brown | F | 76 | 2 years | |
| Steven Burke | M | 63 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Simon Harford | M | 64 | - | |
| Anders Hedegaard | M | 63 | 4 years | |
| Douglas A. Berthiaume | M | 75 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Rémi Droller | M | 48 | 6 years | |
| Peter T. Traynor | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Carrolee Barlow | M | 60 | 2 years | |
| Heather Elizabeth Preston | M | 58 | 10 years | |
| Davey Scoon | M | 78 | 10 years | |
| Cornelius McGillicuddy | M | 83 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Roger Jeffs | M | 62 | 5 years | |
| Henry E. Blair | M | 80 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 26 years |
| Richard F. Syron | M | 80 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Steven J. Burakoff | M | 81 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Andrew Paul Mercieca | M | 58 | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 94 | 94.00% |
| Denmark | 6 | 6.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stephanie Okey
- Personal Network
